Improved survival from lung cancer in British Columbia compared to Scotland—Are different treatment rates the whole story?

Erridge, Sara; Murray, Brian; Williams, Linda; Brewster, David H.; Black, Robert B.; Price, Allan; Murray, Nevin; Sheehan, Finbarr

doi:10.1016/j.lungcan.2008.10.002

Cited by 13 publications

(8 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The median survival in our study was between what was found in a retrospective study comparing lung cancer patients diagnosed in 1995 in Scotland and British Columbia with median survival 3.6 and 7.3 months, respectively. In that study however 9% of the patients were excluded either because of inadequate medical records or because they died on the date of diagnosis or were diagnosed at autopsy (9). A 5‐year survival of 15.7% was higher in a French study of 1738 NSCLC patients (4), compared with 11.0% in our patients (Table 1).…”

Section: Discussionmentioning

confidence: 58%

“…Lung cancer patients have shorter survival than most other cancer patients (5). There are some variations in lung cancer survival between countries (6–9) and among regions within countries (3). Survival rates differ considerably among patients recruited from the general population, patients admitted to referral hospitals (10) and patients offered surgery only (10, 11) or chemotherapy only (12).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Predictors of long‐term survival of lung cancer patients in a Norwegian community

Skaug

Eide

Gulsvik

2010

Clinical Respiratory J

View full text Add to dashboard Cite

Introduction: Few population-based studies are available on more than 5 years survival of lung cancer patients. Objectives: The aims of this report were to study the survival and the predictors of survival in all lung cancer patients in a defined population and to determine whether and how the length of time from symptom onset to confirmed diagnosis (delay time) influenced survival. Methods: In a retrospective study, all incident cases from the Norwegian Cancer Registry and the hospital records in the Haugalandet area from 1990 to 1996 were followed until 31 December 2008. The dates of symptom onset, diagnosis, and death and information about demographics, initial stage, performance status, histology and initial symptoms were recorded. Results: Of a total of 271 patients, 57 (21%) were women, and the mean age at diagnosis was 67.4 years. One-year survival was 29.2%, and five-and 10-year survival was 8.5% and 5.5%, respectively. The median (inter quartile range, IQR) survival time was 5.7 (1.9, 14.1) months and the median (IQR) delay time was 2.2 (1.1, 3.7) months. Twenty-five patients (10% of those who died) had a non-lung cancer cause of death. No weight loss at the time of diagnosis was a significant predictor for long survival in addition to younger age, limited stage, good functional performance and surgical treatment, but delay time for diagnosis had no effect on survival time for lung cancer. Conclusion:In the whole population of lung cancer patients, long-term survival remains poor and is not influenced by the diagnostic delay time.Please cite this paper as: Skaug K, Eide GE and Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J 2011; 5: 50-58.

show abstract

Section: Discussionmentioning

confidence: 58%

Section: Introductionmentioning

confidence: 99%

Predictors of long‐term survival of lung cancer patients in a Norwegian community

Skaug

Eide

Gulsvik

2010

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

“…Of these, 19 UK papers examined 13 study populations, although as these included national and regional populations from different sources, there was some further population overlap. One UK paper also compared treatment in Scotland and Canada [18]. A further nine papers from Canada (2), Sweden (1), Australia (1), Italy (1), France (1), and New Zealand (3) were included.…”

Section: Resultsmentioning

confidence: 99%

Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Previous studies have shown that surgery for lung cancer is less frequently performed in the UK31 32 than elsewhere in Europe33 34 or Canada 20 35. Similarly, lower provision of chemotherapy and radiotherapy has been reported in the UK32 than in Australia,36 Canada20 and Sweden 34. These studies are not directly comparable because they use different methods, data and calendar periods.…”

Section: Discussionmentioning

confidence: 98%

Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

Walters

Maringe

Coleman

et al. 2013

Thorax

460

249

View full text Add to dashboard Cite

Improved survival from lung cancer in British Columbia compared to Scotland—Are different treatment rates the whole story?

Cited by 13 publications

References 58 publications

Predictors of long‐term survival of lung cancer patients in a Norwegian community

Predictors of long‐term survival of lung cancer patients in a Norwegian community

Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis

Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

Contact Info

Product

Resources

About